(July 19, 2015) Ovarian cancer patients who are overweight or obese are often given less chemotherapy per pound of body weight in order to reduce the toxic side effects associated with higher doses, and this in turn may lower their chances of survival, according to a study by researchers at the Rutgers Cancer Institute of … Continued
NASCAR’s Martin Truex Jr.’s girlfriend Sherry Pollex goes to Capitol Hill to advocate for affordable therapy costs, ovarian cancer research funding Pollex, Ovarian Cancer National Alliance support Cancer Treatment Parity Act, to ensure affordable out-of-pocket costs for cancer therapy WASHINGTON, D.C. — Today Sherry Pollex, girlfriend to NASCAR’s Martin Truex Jr. and longtime champion of … Continued
WORLD FAMOUS DESIGNER GARAGE SALE SPONSORED BY QVC SATURDAY, JULY 25TH IN WATER MILL, NY NEW YORK, N.Y. – July 7, 2015 – Donna Karan and Kelly Ripa will host Ovarian Cancer Research Fund’s (OCRF) 18th annual Super Saturday NY, sponsored by QVC. Super Saturday NY will take place on Saturday, July 25, 2015, at … Continued
(July 1, 2015) When bevacizumab was added to standard chemotherapy, ovarian cancer patients with a poor prognosis had an overall survival benefit, according to the ICON7 study published online this week in journal The Lancet Oncology. The study enrolled 1,528 women with newly diagnosed ovarian cancer, high-risk early-stage disease or more advanced disease. The patients were … Continued
When WNY Ovarian Cancer Project co-founder Kathleen Maxian was diagnosed with ovarian cancer, she felt overwhelmed by the amount of negative statistics and information she found on the internet. It took a long 6 months until she met a long-term ovarian cancer survivor who showed her survival was possible. Now a 6-year survivor, Kathleen says … Continued
Several promising advances in the treatment of ovarian cancer were presented at this year’s annual meeting of the American Society of Clinical Oncologists (ASCO). Below is a report from one of our Research Advocates, Katie Hoody. Click the plus sign to read Katie's report.
(6/19/15) OCRF recently welcomed three new members to the Scientific Advisory Committee (SAC), our world-class group of leaders in the ovarian cancer field who review and approve all OCRF research grants. Dineo Khabele, M.D., of Vanderbilt University Medical Center, Celeste Leigh Pearce, Ph.D., M.P.H., of University of Michigan, and Daniel J. Powell, Jr., Ph.D., of … Continued
(June 19, 2015) In a recent study, funded in part by OCRF grants to Dr. Simon Gayther and Dr. Andrew Berchuck, researchers have made important breakthroughs toward understanding the risk and growth of a certain kind of ovarian cancer, known as mucinous ovarian carcinoma, or MOC. The international study involving 1,644 women with MOC and … Continued
(June 18, 2015) A team of researchers, including OCRF grantees Juan Cubillos-Ruiz, PhD, and Alfredo Perales-Puchalt, MD, have discovered how ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor. The findings are published in the June 11 issue of Cell. A therapy that … Continued
(June 17, 2015) Researchers at MD Anderson Cancer Center in Houston have identified a new class of gene mutations that may contribute to outcomes in the treatment of ovarian cancer. Research on the gene family known as ADAMTS could open up a new genetic avenue for the design of ovarian cancer therapies. The findings were … Continued
(June 5, 2015) The Society of Gynecologic Oncology has posted three short videos on YouTube that highlight some of the ovarian cancer research findings presented at the American Society of Clinical Oncology annual meeting last week. Click here to watch the videos, which highlight the results of a number of ovarian cancer clinical trials.
When Turn The Towns Teal®’s founder Gail MacNeil was diagnosed with ovarian cancer almost eighteen years ago, she realized the need for ovarian cancer awareness and saw that nothing was being done that focused solely on ovarian cancer awareness. Turn The Towns Teal grew out of this idea, and has since become a national campaign … Continued
Get email updates about research news, action alerts, and ways to join the fight.
